NPB promoting Telesurveillance oxygen concentrator/monitor as solution to upcoming Medicare cuts.
This article was originally published in The Gray Sheet
Executive Summary
NPB OXYGEN CONCENTRATOR/TELEMONITOR SYSTEM'S COST-SAVING POTENTIAL is being highlighted by Nellcor Puritan Bennett. The company says its Telesurveillance system, introduced Oct. 7 at MedTrade '97 in New Orleans, can save money for home care providers by reducing visits to patients, ensuring compliance with oxygen therapy prescriptions, and allowing more patients to receive care in their homes.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.